DRIL-QUIP INC (DRQ) Fundamental Analysis & Valuation

NYSE:DRQ • US2620371045

Current stock price

15.41 USD
-0.56 (-3.51%)
At close:
15.41 USD
0 (0%)
After Hours:

This DRQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DRQ Profitability Analysis

1.1 Basic Checks

  • DRQ had negative earnings in the past year.
  • In the past year DRQ had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: DRQ reported negative net income in multiple years.
  • In multiple years DRQ reported negative operating cash flow during the last 5 years.
DRQ Yearly Net Income VS EBIT VS OCF VS FCFDRQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of DRQ (-2.68%) is worse than 74.19% of its industry peers.
  • DRQ has a Return On Equity of -3.17%. This is in the lower half of the industry: DRQ underperforms 70.97% of its industry peers.
  • DRQ's Return On Invested Capital of 0.68% is on the low side compared to the rest of the industry. DRQ is outperformed by 79.03% of its industry peers.
Industry RankSector Rank
ROA -2.68%
ROE -3.17%
ROIC 0.68%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A
DRQ Yearly ROA, ROE, ROICDRQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

  • DRQ has a worse Operating Margin (1.61%) than 75.81% of its industry peers.
  • With a Gross Margin value of 28.53%, DRQ perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DRQ has declined.
Industry RankSector Rank
OM 1.61%
PM (TTM) N/A
GM 28.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%
DRQ Yearly Profit, Operating, Gross MarginsDRQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

8

2. DRQ Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DRQ is destroying value.
  • The number of shares outstanding for DRQ has been increased compared to 1 year ago.
  • Compared to 1 year ago, DRQ has a worse debt to assets ratio.
DRQ Yearly Shares OutstandingDRQ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DRQ Yearly Total Debt VS Total AssetsDRQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

  • An Altman-Z score of 4.52 indicates that DRQ is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of DRQ (4.52) is better than 91.94% of its industry peers.
  • DRQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.52
ROIC/WACC0.08
WACC8.32%
DRQ Yearly LT Debt VS Equity VS FCFDRQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 5.60 indicates that DRQ has no problem at all paying its short term obligations.
  • DRQ has a better Current ratio (5.60) than 95.16% of its industry peers.
  • A Quick Ratio of 3.98 indicates that DRQ has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.98, DRQ belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 3.98
DRQ Yearly Current Assets VS Current LiabilitesDRQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

5

3. DRQ Growth Analysis

3.1 Past

  • The earnings per share for DRQ have decreased strongly by -1000.00% in the last year.
  • The Revenue has grown by 29.77% in the past year. This is a very strong growth!
  • Measured over the past years, DRQ shows a small growth in Revenue. The Revenue has been growing by 1.97% on average per year.
EPS 1Y (TTM)-1000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%433.33%
Revenue 1Y (TTM)29.77%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%34.3%

3.2 Future

  • DRQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.14% yearly.
  • The Revenue is expected to grow by 12.73% on average over the next years. This is quite good.
EPS Next Y187.53%
EPS Next 2Y168.04%
EPS Next 3Y111.1%
EPS Next 5Y67.14%
Revenue Next Year20.38%
Revenue Next 2Y13.37%
Revenue Next 3Y10.52%
Revenue Next 5Y12.73%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DRQ Yearly Revenue VS EstimatesDRQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
DRQ Yearly EPS VS EstimatesDRQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4

2

4. DRQ Valuation Analysis

4.1 Price/Earnings Ratio

  • DRQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • DRQ is valuated rather expensively with a Price/Forward Earnings ratio of 19.81.
  • 79.03% of the companies in the same industry are cheaper than DRQ, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, DRQ is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 19.81
DRQ Price Earnings VS Forward Price EarningsDRQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

  • DRQ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DRQ is more expensive than 66.13% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DRQ indicates a slightly more expensive valuation: DRQ is more expensive than 61.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 66.12
EV/EBITDA 8.54
DRQ Per share dataDRQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DRQ's earnings are expected to grow with 111.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y168.04%
EPS Next 3Y111.1%

0

5. DRQ Dividend Analysis

5.1 Amount

  • DRQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DRQ Fundamentals: All Metrics, Ratios and Statistics

DRIL-QUIP INC

NYSE:DRQ (9/6/2024, 8:08:58 PM)

After market: 15.41 0 (0%)

15.41

-0.56 (-3.51%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-01
Earnings (Next)10-24
Inst Owners1.09%
Inst Owner Change0%
Ins Owners1.82%
Ins Owner Change0%
Market Cap530.87M
Revenue(TTM)474.23M
Net Income(TTM)-26.99M
Analysts48
Price Target28.9 (87.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-422.36%
Min EPS beat(2)-789.73%
Max EPS beat(2)-55%
EPS beat(4)0
Avg EPS beat(4)-291.04%
Min EPS beat(4)-789.73%
Max EPS beat(4)-55%
EPS beat(8)2
Avg EPS beat(8)-105.49%
EPS beat(12)2
Avg EPS beat(12)-107.98%
EPS beat(16)3
Avg EPS beat(16)-567.86%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.02%
Revenue beat(4)3
Avg Revenue beat(4)2.74%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)5.56%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)5
Avg Revenue beat(12)-0.6%
Revenue beat(16)6
Avg Revenue beat(16)-1.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.77%
EPS NY rev (1m)-70.45%
EPS NY rev (3m)-70.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.81
P/S 1.12
P/FCF 66.12
P/OCF 14.76
P/B 0.62
P/tB 0.67
EV/EBITDA 8.54
EPS(TTM)-0.63
EYN/A
EPS(NY)0.78
Fwd EY5.05%
FCF(TTM)0.23
FCFY1.51%
OCF(TTM)1.04
OCFY6.77%
SpS13.77
BVpS24.75
TBVpS23.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -3.17%
ROCE 0.86%
ROIC 0.68%
ROICexc 0.86%
ROICexgc 0.94%
OM 1.61%
PM (TTM) N/A
GM 28.53%
FCFM 1.69%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 85.08%
Cap/Sales 5.89%
Interest Coverage 250
Cash Conversion 88.91%
Profit Quality N/A
Current Ratio 5.6
Quick Ratio 3.98
Altman-Z 4.52
F-Score5
WACC8.32%
ROIC/WACC0.08
Cap/Depr(3y)68.2%
Cap/Depr(5y)55.03%
Cap/Sales(3y)5.33%
Cap/Sales(5y)4.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%433.33%
EPS Next Y187.53%
EPS Next 2Y168.04%
EPS Next 3Y111.1%
EPS Next 5Y67.14%
Revenue 1Y (TTM)29.77%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%34.3%
Revenue Next Year20.38%
Revenue Next 2Y13.37%
Revenue Next 3Y10.52%
Revenue Next 5Y12.73%
EBIT growth 1Y247.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year823.58%
EBIT Next 3Y135.99%
EBIT Next 5Y81%
FCF growth 1Y157.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y680.33%
OCF growth 3YN/A
OCF growth 5Y-29.85%

DRIL-QUIP INC / DRQ Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DRIL-QUIP INC (DRQ) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DRQ.


What is the valuation status of DRIL-QUIP INC (DRQ) stock?

ChartMill assigns a valuation rating of 2 / 10 to DRIL-QUIP INC (DRQ). This can be considered as Overvalued.


What is the profitability of DRQ stock?

DRIL-QUIP INC (DRQ) has a profitability rating of 1 / 10.


What is the financial health of DRIL-QUIP INC (DRQ) stock?

The financial health rating of DRIL-QUIP INC (DRQ) is 8 / 10.